S&P/ASX 200 Index (ASX: XJO) shares are down 0.5% to 8,757.9 points on Wednesday.

Among the 11 market sectors, energy is in the lead today, up 2.9%, while materials is the laggard, down 2.3%. 

Meanwhile, on The Bull, three experts give us their views on three ASX 200 shares.

Let’s check them out.   

Resmed CDI (ASX: RMD)

Resmed shares are $31.37 apiece, down 0.2% on Wednesday.

The Resmed share price fell 26.6% to $28.88 in FY26 amid a broader healthcare sector downturn.

Blake Halligan from Catapult Wealth has a buy rating on this ASX 200 healthcare share.

Halligan said:

ResMed is a global leader in sleep apnoea devices and digital health platforms, benefiting from strong structural demand and resilient clinical positioning.

Despite the progression in GLP-1 therapies for treating sleep apnoea, ResMed’s CPAP (continuous positive airway pressure) treatments remain superior at this point in time.

RMD continues to offer appealing growth, income and defensive healthcare exposure.

Goodman Group (ASX: GMG)

The Goodman Group share price is $30.07, down 2% today.

Goodman Group shares fell 9.1% in FY26 and finished the year at $31.13 on 30 June.

Remo Greco from Sanlam Private Wealth has a hold rating on this ASX 200 real estate investment trust (REIT).

Greco said: 

Goodman Group is a global industrial property and data centre developer. Data centres under construction represent 73 per cent of work in progress, according to the company’s third quarter update in fiscal year 2026.

In our view, GMG trades at an elevated valuation, reflecting a lot of potential growth options for the business. The shares have risen from $25.08 on March 30 to trade at $30.645 on July 2.

Investors can continue holding the stock after a recent strong share price performance, but should monitor the news flow to gauge if developments are meeting investor expectations.

Endeavour Group Ltd (ASX: EDV)

Endeavour shares are $3.41 apiece, up 1.6% today.

The Endeavour share price fell 19% to close out FY26 at $3.25 on 30 June.

James Bills from Shaw and Partners has a sell rating on this ASX 200 consumer staples share. 

Bills said: 

Endeavour operates liquor outlets, hotels and gaming facilities. It’s navigating a more challenging consumer environment amid cost pressures in fiercely competitive sectors.

While the company has a strong asset base and market position, we believe near term performance is likely to remain subdued.

With limited catalysts for a re-rating, the stock lacks appeal at this stage of the cycle, in our view.

The shares have fallen from $4.04 on March 2 to trade at $3.375 on July 2.

 

The post Buy, hold, sell: Goodman Group, Endeavour, Resmed shares appeared first on The Motley Fool Australia.

More reading

• ResMed’s $490m MatrixCare sale: What it means
• Why these ASX shares could rise 20% to 30%
• July is historically one of the best months for ASX shares. Can July FY27 deliver?
• 7 ASX 200 shares given buy ratings this week
• 2 ASX shares highly recommended to buy: Experts

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Goodman Group and ResMed. The Motley Fool Australia has positions in and has recommended ResMed. The Motley Fool Australia has recommended Goodman Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

DroneShield Ltd (ASX: DRO) shares have fallen further into the red in Wednesday lunchtime trade.

At the time of writing, the shares are down around 7% and are changing hands for $2.26 a piece. It’s the lowest level the shares have fallen to in 2026 so far.

Today’s decline means DroneShield shares are now down 18% over the past month, are around 32% lower for the year-to-date, and are 11% lower than trading levels this time last year.

What happened to DroneShield shares this year?

There has been a significant shift in sentiment around DroneShield shares over the past couple of months.

The company had a strong start to the year. Its shares were supported by higher global defence budgets, and geopolitical volatility amid conflict in the Middle East. But by May, investors seem to turn their backs on the stock.

A combination of recent governance and regulatory issues and the cooling of conflict in the Middle East has dragged DroneShield’s shares down.

While heightened conflict can increase interest in defence technology, particularly counter-drone systems, signs of easing will do the opposite.

Meanwhile, governance concerns have also weighed on sentiment. DroneShield announced in May that the Australian Securities and Investments Commission (ASIC) had requested the company provide reasonable assistance in connection with an investigation relating to market announcements and share trading in November 2025.

Now there are concerns about ongoing volatility, and that the company’s future growth may not be large enough to justify its share price. 

So the question is, is there anything left ahead for DroneShield shares? Or can the stock fall even further? 

Here’s what the experts think.

Buy, sell or hold?

I wouldn’t jump at the chance to add more DroneShield shares to my portfolio right now, but I wouldn’t cut and run either.

And it looks like analysts are sharply divided too.

TradingView data shows that analysts are split in their outlook for the counter-drone technology stock over the next 12 months, but they all agree we’ll see some element of upside ahead.

Out of four analysts, two have a strong buy rating, and two have a sell or strong sell rating.

The average $3.41 target price still implies a potential 49% upside at the time of writing. The maximum $4.80 target price implies that DroneShield shares could leap another 110%. Meanwhile some are more bearish, tipping the shares to sit unchanged from the current trading price of $2.28 a piece. 

Canaccord Genuity is one analyst with a bullish view on the shares. It renewed its buy rating on Droneshield shares earlier this month, with a 12-month price target of $3.75.

The post DroneShield shares crash another 7% today: Is this the end for the once-soaring defence stock? appeared first on The Motley Fool Australia.

More reading

• Should I buy and hold DroneShield shares for 10 years?
• DroneShield shares are rebounding. Is this the turning point?
• These are the 10 most shorted ASX shares
• Here are the top 10 ASX 200 shares today
• Why did DroneShield shares crash 29% in June?

Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended DroneShield. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Flight Centre Travel Group Ltd (ASX: FLT) shares are trading in the red on Wednesday afternoon.

At the time of writing, the shares are down around 1% and are changing hands for 12.48 a piece.

Despite today’s slump, the shares are up around 12% over the past months and have rebounded an impressive 30% since they fell to a multi-year low of $9.62 in mid-May.

Now the question is, can Flight Centre shares keep flying higher? Or is today’s decline the beginning of the next share price crash?

Here’s what the experts think.

Buy, sell or hold Flight Centre shares? Here’s what brokers tip for the next 12 months.

If broker analysis is anything to go buy, we should see a lot more out of Flight Centre shares over the next year.

Market Index data shows a consensus buy rating for the ASX travel shares over the next 12 months. The average $15.36 target price implies a potential 23% upside ahead, at the time of writing.

TradingView data shows something similar. Out of 17 analysts, 15 have a buy or strong buy rating on Flight Centre shares. Another two rate the shares as a hold, however they all agree an upside ahead.

The average $14.69 target price implies a potential 18% upside, at the time of writing. Although some tip the shares to jump 45% to $18.13 over the next 12 months.

UBS is positive on Flight Centre Travel Group. The broker has retained its buy rating and $14.70 price target on the travel company’s shares.

Morgans also believes the recent share price weakness has created an opportunity for investors. The broker pointed to the company’s financial strength and the potential for a stronger recovery in the second half of FY27. It has a buy recommendation and $14.80 target price on the shares.

Jarden recently upgraded Flight Centre shares to a buy rating with a $15.90 target price.

What could drive the ASX travel stock higher?

Slower-than-expected profit growth, higher travel costs, geopolitical tensions, and inflation concerns pulled the brakes on Travel Centre’s shares earlier this year. 

But improved travel demand and less fuel price volatility has helped investor confidence recently. 

If fuel supply continues to improve and lower interest rates boost consumer spending, we could well see a stronger rebound ahead.

The company is also due to release its FY26 earnings results in late-August. If the result comes in ahead of market expectations we could see another lift in the share price. 

The post Flight Centre shares rebound 30% from multi-year low: Can they keep climbing higher? appeared first on The Motley Fool Australia.

More reading

• 7 ASX 200 shares given buy ratings this week
• Why I want to own these ASX shares brokers rate as buys
• These are the 10 most shorted ASX shares
• Here are the 10 most shorted ASX shares
• ASX 200 retail shares outperform on growing hopes interest rates have peaked

Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Flight Centre Travel Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.